The 45 largest public listed companies of Indonesia, components of the LQ45 index, are major actors in the economy of Indonesia, Southeast Asia, and the world. With a short presentation of each company, its sector, and logo, this following list provides useful information and links to the company’s website and its stock quote.
Overview of healthcare in Vietnam [market analysis]
The transition of Vietnam to an emerging market economy goes along several changes in habits and income of its population. With increasing spending, modernization of medical practices, improvement of the healthcare system and the development of technologies, numerous opportunities arise in the Vietnamese healthcare sector.
Overview of healthcare in Myanmar [market analysis]
With the opening of Myanmar’s economy, the healthcare sector has important difficulties to tackle to provide access to more and better services for a larger part of the population. In this transition, the country also presents very interesting opportunities for healthcare businesses and professionals.
Overview of healthcare in Southeast Asia
With a growing population and personal disposable income, the healthcare sector is looking very attractive in Southeast Asia. Healthcare expenditure is still low but steadily growing, and though the quality of services provided is uneven between the different countries, it is also improving throughout the region.
Thailand’s healthcare sector overview
With a high quality of medical services and affordable prices, Thailand has become a major hub for medical tourism in Asia. Thailand’s facilities, technologies, quality of medical services and expertise all factor in to attract healthcare services of medical devices, pharmaceuticals and medical food.
Overview of the healthcare sector in Asia
Healthcare spending is growing rapidly in Asia, giving rise to numerous opportunities for medical services providers, pharmaceutical companies, health insurers and other companies involved in healthcare. This report from the Economist Intelligence Unit analyses competition, challenges and opportunities for this sector in Asia.
Competition and profitability of pharmaceuticals in Asia
The changing landscape of Asian economies is modifying the dynamics of competition and profitability between corporations. In this report from the Economist Intelligence Unit, several demographic, legal and financial trends are analyzed to search for market insights as well as best practices for corporate finance and strategy in Asia.